文献速递妇科

孤立性浅表腹膜型子宫内膜异位症的手术疼痛改善研究

Surgery for Pain Symptoms in Women With Isolated Superficial Peritoneal Endometriosis.
PubMed 文献 · J Minim Invasive Gynecol · 2026-04-02

本研究为回顾性队列研究,纳入250例疑似孤立性浅表腹膜型子宫内膜异位症(iSPE)且术前影像阴性、因疼痛行切除术的女性。手术确诊iSPE者158例(63.2%),无病变者92例(36.8%)。iSPE组在各随访时段疼痛改善率均显著更高,子宫内膜异位症是疼痛改善的最强独立预测因素。

要点

  • iSPE组术后6-12周、12周-12个月、>12个月疼痛改善率分别为77.7%、80.9%、82.6%,均显著高于无病变组。
  • 手术确诊子宫内膜异位症是各随访时段疼痛改善的最强独立预测因素(OR 2.6-4.4)。
  • 术后激素治疗与长期改善相关,合并子宫腺肌症则改善可能性更低。

核心结论

  • 在本队列中,腹腔镜手术与iSPE患者相比无子宫内膜异位症者具有显著更高的疼痛改善率。
  • 部分无 detectable 病变者疼痛缓解提示盆腔痛的多因素性质。
  • 需前瞻性研究确认并优化患者选择与治疗策略。

研究设计与样本

  • 回顾性队列研究,三级子宫内膜异位症转诊中心。
  • 纳入2019-2024年18-45岁、有子宫内膜异位症相关疼痛、术前影像阴性、因疑似iSPE行切除术的女性。
  • 共250例,其中手术确诊iSPE 158例(63.2%),无病变92例(36.8%)。

主要发现

  • iSPE组疼痛改善率在6-12周为77.7% vs 56.9%,12周-12个月为80.9% vs 54.1%,>12个月为82.6% vs 52.9%(均p<.01)。
  • 子宫内膜异位症是各随访时段疼痛改善的最强独立预测因素:6-12周OR=2.6(95%CI 1.4-4.7),12周-12个月OR=3.3(95%CI 1.0-10.2),>12个月OR=4.4(95%CI 2.1-9.2)。
  • 长期改善更可能见于术后接受激素治疗者,合并子宫腺肌症者改善可能性更低。
  • 痛经、非经期盆腔痛、性交痛及胃肠道症状改善最明显。

临床怎么用

  • 对疑似iSPE且术前影像阴性的疼痛患者,腹腔镜切除手术可显著改善疼痛,尤其痛经、非经期盆腔痛、性交痛及胃肠道症状。
  • 术后激素治疗可能与长期疼痛改善相关,合并子宫腺肌症者需预期改善可能性较低。
  • 无病变者仍有部分疼痛改善,提示盆腔痛多因素性,术前咨询应涵盖此点。

局限性

  • 回顾性设计,疼痛结局基于病历和结构化术后问卷。
  • 部分OR的95%CI较宽(如12周-12个月OR=3.3,95%CI 1.0-10.2),估计精度有限。
  • 需前瞻性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To evaluate the change in overall pain after surgery in participants with suspected isolated superficial peritoneal endometriosis (iSPE), and to identify improvement predictors. DESIGN: Retrospective cohort study. SETTING: Tertiary endometriosis referral center. PARTICIPANTS: Women aged 18 to 45 years with endometriosis-associated pain symptoms and negative preoperative imaging for deep infiltrating or ovarian endometriosis who underwent excisional surgery for suspected iSPE between 2019 and 2024. INTERVENTIONS: Participants were classified into the endometriosis and no endometriosis groups based on surgical findings. Pain outcomes were assessed at short-term (6-12 weeks), medium-term (12 weeks-12 months), and long-term (>12 months) follow-up, using medical records and a structured postoperative questionnaire. MEASUREMENTS AND MAIN RESULTS: A total of 250 participants were included; 158 (63.2%) with surgically confirmed iSPE and 92 (36.8%) with no evidence of disease. Baseline characteristics and preoperative symptoms were similar between groups. Participants with iSPE reported significantly greater pain improvement rates at all follow-up intervals (77.7% vs 56.9% at 6-12 weeks; 80.9% vs 54.1% at 12 weeks-12 months; 82.6% vs 52.9% at >12 months; all p <.01). Endometriosis was the strongest independent predictor of postoperative pain improvement at all follow-up intervals (6-12 weeks: OR = 2.6; 95% CI, 1.4-4.7; 12 weeks-12 months: OR = 3.3; 95% CI, 1.0-10.2; >12 months: OR = 4.4; 95% CI, 2.1-9.2). Long-term improvement was more likely with postoperative hormonal therapy and less likely in participants with adenomyosis. Improvement was greatest for dysmenorrhea, nonmenstrual pelvic pain, dyspareunia, and gastrointestinal symptoms. CONCLUSION: In our cohort, laparoscopic surgery was associated with significantly greater pain improvement rates in participants with iSPE compared with those without endometriosis. Pain relief in some participants without detectable disease highlights the multifactorial nature of pelvic pain. Prospective studies are needed to confirm these findings and optimize patient selection and treatment strategies.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Maslenko M, Tabib Y, Saar TD, et al. Surgery for Pain Symptoms in Women With Isolated Superficial Peritoneal Endometriosis. J Minim Invasive Gynecol. 2026. PMID: 41935570. doi:10.1016/j.jmig.2026.03.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。